is metformin a glp-1 drug glp 1 or Comparing Glucagon‐like peptide‐1 receptor agonists versus in drug‐naive patients: nationwide cohort study - Sørensen - 2024 Metformin vs GLP-1: Key Differences

Key benefits for perimenopausal women: Targets visceral and subcutaneous fat accumulation that tends to increase as estrogen declines and metabolism slows Does not affect blood sugar or cause stimulant-related side effects such as anxiety or elevated heart rate Supports fat loss while preserving lean muscle tissue, important for maintaining metabolic rate during hormonal transition Administration method: Subcutaneous injection into abdominal fatty tissue, typically 2 inches from the navel

Youve probably seen it in skincare serums, promising smoother, firmer, glassier skin

Product information Epithalon research record Clear product, batch, storage, dispatch and document information for this powder vial

mSphere (2019) 4(1):e0068918